Computerized Anger-Reduction Treatment for Smoking Cessation

Completed · Not applicable

Conditions studied: Anger, Smoking Cessation

In brief

Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal nicotine patch therapy and either anger-reduction treatment or a control intervention. They will be assessed throughout treatment and up until three months after a scheduled mid- treatment quit date. The investigators propose to test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.

Key facts

Study ID

NCT02413814

Run by

Florida State University

People needed

100

Starts

2015-04-01

Expected to finish

2019-07-30

Last updated by the study team

2021-01-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Elevated levels of trait anger (scoring 22 or higher on the STAXI-trait)
• Currently smoking an average of 8 cigarettes per day
• Must be a regular (daily) smoker for at least 1 year
• Willing to make a serious attempt to quit smoking
• Must report motivation to quit in the next month (30 days) of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation)
• Have not decreased the number of cigarettes by more than half in the past six months
• Must be an English speaker

You may not qualify if…

• Current substance dependence (excluding nicotine dependence)
• Current use of other tobacco products
• Currently receiving cognitive therapy or therapy for problematic anger
• Evidence of serious suicidal intent requiring hospitalization or immediate treatment
• Limited mental competency and the inability to give informed, written consent
• Evidence of psychotic-spectrum disorders
• Changes in medication over the last month

Where it is running

• Florida State University, Department of Psychology — Tallahassee, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.